Pravastatin Sodium
Product Images NDC 66116-346

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 66116-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dad83d68 F35a 42ca A65c F95677e1c9ca 01)

Chemical structure diagram of pravastatin sodium, displaying the molecular arrangement including hydroxyl groups, carboxylate sodium salt, and ring structures visible in the image.*

FDA Label Image

Figure (Dad83d68 F35a 42ca A65c F95677e1c9ca 02)

A survival distribution line graph comparing the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over 5 years since randomization between placebo and pravastatin groups. The graph shows higher event-free proportions for pravastatin, with a significant Logrank P-value of 0.0001.*

FDA Label Image

Pravastatin Sodium Tablets, Usp 20mg #30 (Dad83d68 F35a 42ca A65c F95677e1c9ca 03)

Pravastatin Sodium Tablets USP 20 mg, 30 tablets per bottle, label from MedVantx, Inc. The label indicates controlled room temperature storage, sample only status, and includes manufacturer and distributor information. It also shows a barcode and contact details for free shipping and home delivery.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.